(Q24315836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

GOA release 2020-03-11

Receptor tyrosine kinase like orphan receptor 2

1 reference

positive regulation of cell migration

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Kazuhito Morioka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Koichi Matsuda

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5

Toyomasa Katagiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

Yataro Daigo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

15

Yusuke Nakamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2

Chizu Tanikawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Kensuke Ochi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hirotaka Kawano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hiroshi Kawaguchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Akira Myoui

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hideki Yoshikawa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Norifumi Naka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nobuto Araki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ikuo Kudawara

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Makoto Ieguchi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kozo Nakamura

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

15 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1227-1233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

Frequent beta-catenin abnormalities in bone and soft-tissue tumors.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Metastatic osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

One gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

The Ror receptor tyrosine kinase family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

A review of clinical and molecular prognostic factors in osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

The Wnt gene family in tumorigenesis and in normal development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Key cancer cell signal transduction pathways as therapeutic targets.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

CDC20, a potential cancer therapeutic target, is negatively regulated by p53.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Survival data for 648 patients with osteosarcoma treated at one institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Mechanisms of Wnt signaling in development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Side population cells isolated from mesenchymal neoplasms have tumor initiating potential

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

A complex pattern of chemokine receptor expression is seen in osteosarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Chemotherapy resistance in osteosarcoma: current challenges and future directions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Stem-like cells in bone sarcomas: implications for tumorigenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

Sarcoma derived from cultured mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01165.X

7 January 2021

10.1111/J.1349-7006.2009.01165.X

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19486338%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017